Skip to main content
. 2017 Feb 17;31(6):890–898. doi: 10.1038/eye.2017.7

Figure 1.

Figure 1

The mean change in CST in microns according to OCT during 28 weeks of follow-up (n=47; a). (b–c) A subgroup analysis of CST changes during the study. (b) CST changes in eyes that received additional injection at week 20 (n=35) and eyes without additional injection (n=12). There were similar CST changes in both groups. (c) CST changes along the study according to the number of bevacizumab injections prior to enrollment to the study. There were similar CST changes in both groups. *P<0.05 for the comparison of baseline vs follow-up examination in the same group. Error bars represent SEM.